Graham
GHM
84.34
-3.94
-4.46%
Graham
US · GHM
#3261 by market cap
84.34
-3.94
-4.46%
Live - 5344 symbols - heartbeat 261s ago
· 2026-10-08 08:03
Pre-market
83.70
-0.76%
After-hours
84.86
+0.62%
- Market cap
- 989.90M
- P/E (TTM)i
- 81.88
- P/Bi
- 5.15
- EPSi
- 1.12
- Div yieldi
- 0.00%
- 52W posi
- 43%
Reader sentiment
Are you bullish or bearish on GHM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.61, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +16.86% YoY
Margins
- Gross margin
- 23.54%
- Operating margin
- 6.12%
- Net margin
- 5.10%
Key ratios & quality
- Enterprise valuei
- 998.15M
- PEG ratioi
- 0.37
- Altman Z-Scorei
- 4.61
PEG uses trailing P/E against the 3-year net income growth rate (224.15%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 91.83M | 90.60M | 97.49M | 122.81M | 157.12M | 185.53M | 209.90M | 245.29M |
| Gross profit | 21.91M | 18.15M | 20.47M | 9.13M | 25.41M | 40.59M | 52.86M | 57.75M |
| Selling & admin expenses | 17.88M | 16.88M | 17.47M | 20.39M | 23.06M | 32.22M | 37.14M | 41.56M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 4.03M | 652.00K | 3.00M | -11.34M | 1.25M | 6.92M | 15.19M | 15.02M |
| Pretax profit | -145.00K | 2.31M | 3.27M | -11.22M | 561.00K | 5.57M | 15.41M | 14.76M |
| Tax | 163.00K | 440.00K | 893.00K | -2.44M | 194.00K | 1.02M | 3.18M | 2.26M |
| Net profit | -308.00K | 1.87M | 2.37M | -8.77M | 367.00K | 4.56M | 12.23M | 12.50M |
| Basic EPS | 0 | 0 | 0 | -1 | 0 | 0 | 1 | 1 |
| Diluted EPS | -0.03 | 0.19 | 0.24 | -0.83 | 0.03 | 0.42 | 1.11 | 1.12 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 59.35M | 55.49M | 66.03M | 56.70M | 67.08M | 71.34M |
| Gross profit | 16.01M | 14.72M | 14.31M | 13.47M | 15.25M | 17.80M |
| Selling & admin expenses | 10.32M | 9.40M | 9.79M | 10.13M | 12.25M | 12.55M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 5.52M | 4.96M | 4.27M | 3.12M | 2.66M | 4.15M |
| Pretax profit | 5.57M | 5.01M | 4.22M | 3.20M | 2.32M | 4.18M |
| Tax | 1.17M | 418.00K | 1.13M | 358.00K | 351.00K | 271.00K |
| Net profit | 4.40M | 4.60M | 3.09M | 2.85M | 1.97M | 3.91M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.40 | 0.42 | 0.28 | 0.25 | 0.18 | 0.33 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 134.78M | 126.68M | 120.25M | 87.22M | 110.07M | 126.33M | 141.37M | 156.45M |
| Cash & ST investments | 77.75M | 73.00M | 65.03M | 14.74M | 18.26M | 16.94M | 21.58M | 6.58M |
| Inventory | 24.67M | 22.29M | 17.33M | 17.41M | 26.29M | 33.41M | 40.03M | 50.76M |
| Total assets | 156.27M | 148.12M | 144.28M | 183.69M | 203.92M | 233.88M | 264.11M | 323.62M |
| Total current liabilities | 54.89M | 49.23M | 43.57M | 59.42M | 86.17M | 118.21M | 136.15M | 156.27M |
| Short-term debt | 51.00K | 193.00K | 67.00K | 3.08M | 3.05M | 1.26M | 1.30M | 1.83M |
| Long-term debt | -- | -- | -- | 16.38M | 9.74M | -- | -- | 13.00M |
| Total liabilities | 57,304,000.00 | 51,396,000.00 | 46,351,000.00 | 87,197,000.00 | 106,985,000.00 | 128,313,000.00 | 144,533,000.00 | 183,301,000.00 |
| Total equity | 98.97M | 96.72M | 97.93M | 96.49M | 96.93M | 105.57M | 119.58M | 140.32M |
| Retained earnings | 93.85M | 91.39M | 89.37M | 77.08M | 77.44M | 82.00M | 94.23M | 106.73M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 141.37M | 127.52M | 159.45M | 163.81M | 156.45M | 198.38M |
| Cash & ST investments | 21.58M | 10.75M | 20.58M | 22.25M | 6.58M | 26.95M |
| Inventory | 40.03M | 37.39M | 42.43M | 48.52M | 50.76M | 49.44M |
| Total assets | 264.11M | 252.34M | 286.99M | 292.93M | 323.62M | 363.96M |
| Total current liabilities | 136.15M | 121.06M | 151.94M | 154.67M | 156.27M | 161.12M |
| Short-term debt | 1.30M | 1.38M | 1.41M | 1.48M | 1.83M | 1.82M |
| Long-term debt | -- | -- | -- | -- | 13.00M | -- |
| Total liabilities | 144,533,000.00 | 128,955,000.00 | 159,400,000.00 | 161,617,000.00 | 183,301,000.00 | 171,764,000.00 |
| Total equity | 119.58M | 123.38M | 127.59M | 131.31M | 140.32M | 192.20M |
| Retained earnings | 94.23M | 98.82M | 101.91M | 104.76M | 106.73M | 110.64M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 7.92M | 1.24M | -1.72M | -2.22M | 13.91M | 28.12M | 24.32M | 15.93M |
| Depreciation & amortization | 2.21M | 1.97M | 1.95M | 5.60M | 5.99M | 5.43M | 5.94M | 7.84M |
| Free cash flow | 5.78M | -1.18M | -3.88M | -4.54M | 10.17M | 18.89M | 5.36M | -121.00K |
| Dividends paid | -3.83M | -4.25M | -4.39M | -3.52M | -- | -- | -- | -- |
| Stock buybacks / issuance | 161.00K | -206.00K | -23.00K | -41.00K | -21.00K | 418.00K | -201.00K | -709.00K |
| Ending cash balance | 15.02M | 32.96M | 59.53M | 14.74M | 18.26M | 16.94M | 21.58M | 6.58M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -3.56M | -2.26M | 13.58M | 4.76M | -151.00K | -12.65M |
| Depreciation & amortization | 1.56M | 1.52M | 1.65M | 2.01M | 2.67M | 2.72M |
| Free cash flow | -8.71M | -9.26M | 9.44M | 2.43M | -2.72M | -15.26M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -535.00K | 0 | 458.00K | 0 | -1.17M | 50.00M |
| Ending cash balance | 21.58M | 10.75M | 20.58M | 22.25M | 6.58M | 26.95M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -0.30 | 1.91 | 2.44 | -9.02 | 0.38 | 4.50 | 10.86 | 9.62 |
| ROA %i | -0.21 | 1.23 | 1.62 | -5.35 | 0.19 | 2.08 | 4.91 | 4.25 |
| ROIC %i | -1.35 | 0.83 | 2.32 | -7.64 | 0.81 | 4.13 | 10.20 | 8.71 |
| 5-year avg ROE %i | 2.76 | 0.50 | -0.10 | -2.81 | -0.92 | 0.04 | 1.83 | 3.27 |
| EBIT margin %i | -0.14 | 2.57 | 3.36 | -8.77 | 1.04 | 3.14 | 7.24 | 6.12 |
| FCF / sales %i | 6.29 | -- | -- | -- | 6.47 | 10.18 | 2.55 | -- |
| Current ratioi | 2.46 | 2.57 | 2.76 | 1.47 | 1.28 | 1.07 | 1.04 | 1.00 |
| Quick ratioi | 1.89 | 2.10 | 2.35 | 1.15 | 0.95 | 0.76 | 0.71 | 0.65 |
| Debt / assetsi | 0.09 | 0.22 | 0.10 | 14.66 | 9.99 | 3.32 | 2.60 | 6.24 |
| LT debt / equityi | 0.10 | 0.14 | 0.07 | 24.72 | 17.88 | 6.17 | 4.65 | 13.09 |
| Interest coveragei | -11.08 | 193.67 | 298.00 | -23.92 | 1.53 | 23.48 | -- | -- |
| Revenue CAGR (3Y) %i | 0.66 | -0.43 | 7.93 | 10.18 | 20.14 | 23.92 | 19.56 | 16.01 |
| Net income CAGR (3Y) %i | -- | -28.04 | -- | -- | -41.91 | 24.27 | -- | 224.15 |
| FCF CAGR (3Y) %i | -31.01 | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.86 | 11.97 | 11.39 | 12.15 | 9.62 | 7.49 |
| ROA %i | 4.91 | 5.58 | 5.10 | 5.36 | 4.25 | 3.83 |
| ROIC %i | 10.20 | 11.28 | 10.78 | 11.54 | 8.71 | 7.18 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.24 | 7.86 | 7.44 | 7.53 | 6.12 | 5.44 |
| FCF / sales %i | 2.55 | -- | -- | -- | -- | -- |
| Current ratioi | 1.04 | 1.05 | 1.05 | 1.06 | 1.00 | 1.23 |
| Quick ratioi | 0.71 | 0.71 | 0.74 | 0.72 | 0.65 | 0.89 |
| Debt / assetsi | 2.60 | 2.64 | 2.21 | 2.07 | 6.24 | 1.87 |
| LT debt / equityi | 4.65 | 4.28 | 3.86 | 3.48 | 13.09 | 2.59 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Design and manufacture mission critical fluid, power, heat transfer, vacuum and advanced mixing100.00%
Region
United States (US)85.46%
Asia5.15%
Canada4.57%
Middle East2.85%
All other1.45%
South America0.51%
Quote time 2026-10-08 08:03:48 · For reference only, not investment advice and not tailored to your situation.